Search clinical trials for: AMX0035

Total 17 results

Amylyx Pharmaceuticals Inc.
Massachusetts General Hospital Neurology Clinical Research Institute

Completed

Open Label Extension Study of AMX0035 in Patients With ALS (CENTAUR-OLE)

Amyotrophic Lateral Sclerosis | ALS

United States
Amylyx Pharmaceuticals Inc.

Active, not recruiting

Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS

ALS

United States
Amylyx Pharmaceuticals Inc.

Recruiting

AMX0035 and Progressive Supranuclear Palsy (ORION)

Neurodegenerative Diseases | Progressive Supranuclear Palsy | Atypical Parkinsonism | PSP

United States
Amylyx Pharmaceuticals Inc.

Approved for marketing

An Intermediate Size Expanded Access Protocol of AMX0035 for ALS

Amyotrophic Lateral Sclerosis

United States, Puerto Rico
Amylyx Pharmaceuticals Inc.

Completed

A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
Amylyx Pharmaceuticals Inc.

Enrolling by invitation

Extension Study Evaluating The Safety And Tolerability of AMX0035

Amyotrophic Lateral Sclerosis

Belgium, Spain, Netherlands, United Kingdom, Sweden, France, Germany, Ireland, Italy, Poland, Portugal
Amylyx Pharmaceuticals Inc.

Active, not recruiting

Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment (Phoenix)

Amyotrophic Lateral Sclerosis

United States, Belgium, Spain, Netherlands, United Kingdom, Germany, Sweden, France, Ireland, Italy, Poland, Portugal
Annexon, Inc.

Recruiting

Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States, Canada
Annexon, Inc.

Completed

An Open Label Study of ANX005 in Subjects With, or at Risk for, Manifest Huntington's Disease

Huntington Disease

United States
Aummune Ltd.

Recruiting

Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

Solid Tumor

Israel
Annexon, Inc.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Warm Autoimmune Hemolytic Anemia (wAIHA)

United States
Annexon, Inc.

Terminated

Single Dose Study of ANX005 in Healthy Volunteers

Safety and Tolerability in Healthy Volunteers

Australia
Amylyx Pharmaceuticals Inc.

Active, not recruiting

AMX0035 in Adult Patients With Wolfram Syndrome

Wolfram Syndrome

United States
Amylyx Pharmaceuticals Inc.
ALS Association; ALS Finding a Cure; Northeast ALS Consortium; Neurological Clinical... and other collaborators

Completed

AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) (CENTAUR)

Central Nervous System Diseases | Nervous System Diseases | Neuromuscular Diseases | Neurodegenerative Diseases | Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Spinal Cord Diseases | TDP-43 Proteinopathies

United States
Annexon, Inc.

Recruiting

Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome

Guillain-Barre Syndrome

Bangladesh, Philippines
Amylyx Pharmaceuticals Inc.
Alzheimer's Association; Alzheimer's Drug Discovery Foundation

Completed

Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (PEGASUS)

Alzheimer Disease

United States
Annexon, Inc.
International Centre for Diarrhoeal Disease Research, Bangladesh; ResearchPoint...

Completed

A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

Guillain-Barré Syndrome

Denmark, Bangladesh

Search clinical trials for: AMX0035

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations